CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 15, 2018--
Pharmaceuticals, Inc. (NASDAQ:RARX), a clinical stage
biopharmaceutical company focusing on the development of next-generation
therapeutics for the treatment of complement-mediated diseases, today
announced that Doug Treco, Ph.D., President and Chief Executive Officer,
will present at the RBC Capital Markets 2018 Global Healthcare
Conference on Wednesday, February 21, 2018 at 8:00 a.m. E.T. The
conference is being held at the Lotte New York Palace Hotel.
A live webcast of the presentation can be accessed by visiting the
investor relations section of the Company’s website, www.rapharma.com.
A replay of the presentation will also be available and archived on the
site for three weeks.
About Ra Pharmaceuticals
Ra Pharmaceuticals is a clinical stage biopharmaceutical company
focusing on the development of next-generation therapeutics for
complement-mediated diseases. The Company discovers and develops
peptides and small molecules to target key components of the complement
cascade. For more information, please visit: www.rapharma.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180215005403/en/
Source: Ra Pharmaceuticals
Natalie Wildenradt, 646-681-8192